COLINZ LABORATORIES LTD. Share Price

Colinz Laboratories Ltd. is an India-based company that is engaged in the manufacturing and marketing of pharmaceutical formulations, particularly in the gynecological sector. It is engaged in the manufacturing and marketing various allopathic, ayurvedic, and nutraceuticals pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals and ointments, among others. The company has specialized products for Gynecology, cardiology, gastroenterology, and others. Its oncology products include imitinib, erlotinib, letrozole, exemestane, bortezomib, fludarabine phosphate, and doxorubicin. Its Ayurvedic products include anti-diarrhoeals, anti-pyretics, anti-inflammatories, anti-spasmodics, cough syrups, appetite stimulating agents, and memory boosters. Its nutraceuticals products include spirulina tabs/caps, spirulina with vitamins & minerals, omega 3 fatty acid caps in softgel, codliver oil with vitamin caps in soft gel, collagen, and glucosamine & chondroitin tabs.As of 25 May 2026, COLINZ LABORATORIES LTD. share price is ₹46.20. The stock opened at ₹46.20, compared to its previous close of ₹44.00. During today's trading session, COLINZ LABORATORIES LTD. share price moved in the range of ₹46.18 to ₹46.20, with an average price of ₹46.19 for the day. Looking at its last 52-week, the stock has touched a low of ₹46.18 and a high of ₹46.20.

The market capitalization of COLINZ LABORATORIES LTD. is ₹6 Crs, with a P/E ratio of 10.8 and a dividend yield of 0.00%.